The authors tested a Doxycycline (Dox)-inducible “all-in-one” lentiviral vector (Lv.TII vectors) design which expresses a reverse transactivator protein (rtTA2S-M2) in human hematopoietic cells. Functionality of Dox-inducible hCDD expression was demonstrated by a more than 10-fold increase in cytosine arabinoside (Ara-C) resistance of Lv.TII.CDD transduced K562 cells. In addition, Lv.TII.CDD transduced CD34+ derived myeloid cells were protected from up to 300nM Ara-C.
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.
The authors tested a Doxycycline (Dox)-inducible “all-in-one” lentiviral vector (Lv.TII vectors) design which expresses a reverse transactivator protein (rtTA2S-M2) in human hematopoietic cells. Functionality of Dox-inducible hCDD expression was demonstrated by a more than 10-fold increase in cytosine arabinoside (Ara-C) resistance of Lv.TII.CDD transduced K562 cells. In addition, Lv.TII.CDD transduced CD34+ derived myeloid cells were protected from up to 300 nM Ara-C.
www.geg-tech.com/Vectors